Industry Warns Of ‘Conflicting’ Clinical Requirements For Drug-Device Combinations In EU
Executive Summary
EU regulators are being urged to get their skates on and publish guidance on new clinical requirements that will kick in soon for integral drug-device combination products.
You may also be interested in...
Here At Last: EU Guidance On Quality Rules For Drug-Device Combinations
New EU guidance includes more information for
Advice At Last For Drug Makers Worried About New Medical Device Rules
An upcoming requirement that Europe’s new medical device regulation has introduced for companies making drugs with integral medical devices will not be applied retrospectively, according to the European Medicines Agency.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.